Production (Stage)
SpringWorks Therapeutics, Inc.
SWTX
$46.49
$0.010.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.11% | 20.60% | 9.77% | -1.06% | -17.31% |
| Total Depreciation and Amortization | 79.19% | 108.04% | 115.97% | 136.39% | 135.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.90% | 15.51% | 23.95% | 25.51% | 28.38% |
| Change in Net Operating Assets | -236.28% | -6,394.17% | -1,086.94% | -299.57% | -138.14% |
| Cash from Operations | 31.04% | 21.18% | 2.56% | -27.50% | -37.33% |
| Capital Expenditure | 21.69% | 39.73% | 90.41% | 74.69% | 53.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 421.85% | 63.73% | 28.01% | -1.95% | 71.80% |
| Cash from Investing | 374.79% | 85.72% | 32.44% | 6.00% | 70.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.88% | -95.59% | 75,287.17% | -9.17% | -10.46% |
| Repurchase of Common Stock | -101.06% | -201.36% | -220.69% | -217.96% | -211.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -101.78% | -98.39% | 14,307.17% | -10.84% | -12.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -446.83% | -197.88% | 96.18% | -177.15% | -23.64% |